MML Investors Services’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-4,324
| Closed | -$219K | – | 2524 |
|
2023
Q4 | $219K | Buy |
+4,324
| New | +$219K | ﹤0.01% | 2262 |
|
2023
Q3 | – | Sell |
-5,956
| Closed | -$244K | – | 2334 |
|
2023
Q2 | $244K | Buy |
+5,956
| New | +$244K | ﹤0.01% | 2050 |
|
2022
Q3 | – | Sell |
-29,479
| Closed | -$1.09M | – | 2113 |
|
2022
Q2 | $1.09M | Buy |
29,479
+1,357
| +5% | +$50.2K | 0.01% | 1008 |
|
2022
Q1 | $1.04M | Buy |
28,122
+2,905
| +12% | +$108K | 0.01% | 1066 |
|
2021
Q4 | $767K | Buy |
25,217
+603
| +2% | +$18.3K | 0.01% | 1185 |
|
2021
Q3 | $826K | Buy |
24,614
+1,828
| +8% | +$61.3K | 0.01% | 1107 |
|
2021
Q2 | $909K | Buy |
22,786
+2,890
| +15% | +$115K | 0.01% | 1040 |
|
2021
Q1 | $895K | Buy |
+19,896
| New | +$895K | 0.01% | 968 |
|
2020
Q1 | – | Sell |
-3,344
| Closed | -$202K | – | 1474 |
|
2019
Q4 | $202K | Sell |
3,344
-86
| -3% | -$5.2K | ﹤0.01% | 1431 |
|
2019
Q3 | $205K | Sell |
3,430
-704
| -17% | -$42.1K | ﹤0.01% | 1387 |
|
2019
Q2 | $266K | Buy |
4,134
+1,036
| +33% | +$66.7K | ﹤0.01% | 1353 |
|
2019
Q1 | $251K | Buy |
+3,098
| New | +$251K | ﹤0.01% | 1358 |
|
2018
Q4 | – | Sell |
-4,669
| Closed | -$241K | – | 1548 |
|
2018
Q3 | $241K | Buy |
+4,669
| New | +$241K | ﹤0.01% | 1395 |
|